Peptron Inc. | Cash Flow

Fiscal year is January-December. All values KRW Thousands.
2013
2014
2015
2016
2017
Net Income before Extraordinaries
2,059,417.00
3,046,282.00
2,730,419.60
3,190,976.00
4,426,816.70
Depreciation, Depletion & Amortization
562,857.00
578,393.00
597,960.00
602,225.00
594,223.00
Other Funds
-
-
3,924.40
136,509.10
74,198.00
Funds from Operations
1,471,241.00
1,878,822.20
1,975,986.70
2,470,757.60
3,175,618.30
Changes in Working Capital
151,438.00
1,166,481.00
379,866.00
259,043.00
2,449,917.60
Net Operating Cash Flow
1,319,803.00
3,045,303.20
2,355,852.70
2,729,800.60
5,625,535.90
Capital Expenditures
124,755.80
732,206.30
334,946.20
2,984,633.10
21,874,520.20
Sale of Fixed Assets & Businesses
600.00
-
3,800.00
82,863.60
-
Purchase/Sale of Investments
40,700.00
4,055,421.10
9,760,332.00
30,306,522.10
25,136,783.30
Net Investing Cash Flow
83,455.80
4,787,627.30
10,091,478.20
33,388,291.50
3,271,113.20
Issuance/Reduction of Debt, Net
11,980.10
1,756,942.00
66,666.00
200,000.00
-
Net Financing Cash Flow
11,980.10
8,256,935.50
12,584,761.00
39,171,383.80
74,198.00
Net Change in Cash
1,415,380.90
428,073.20
146,820.00
2,935,770.40
2,581,851.80
Free Cash Flow
1,381,993.60
3,654,187.50
2,605,197.40
5,514,690.00
27,471,156.10
Other Sources
-
-
-
-
20,000.00
Change in Capital Stock
-
6,499,993.50
12,655,351.30
39,507,892.90
-
Exchange Rate Effect
142.00
4,068.30
9,389.90
117,521.30
153,231.10
Other Uses
-
-
-
180,000.00
11,150.00

About Peptron

View Profile
Address
37-24 Yuseong-daero 1628beon-gil
Daejeon DE 34054
Korea, Republic Of
Employees -
Website http://www.peptron.co.kr
Updated 09/14/2018
Peptron, Inc. engages in the development of peptide-based medicines and novel drugs. Its products include medicines for prostate cancer, hyperpituitarism, diabetes, degenerative neuronal disease, and obesity, peptide materials, and cosmetics. The company was founded on November 21, 1997 and is headquartered in Daejeon, South Korea.